Multi-Omics Analysis of the Anti-tumor Synergistic Mechanism and Potential Application of Immune Checkpoint Blockade Combined With Lenvatinib

Multi-Omics Analysis of the Anti-tumor Synergistic Mechanism and Potential Application of Immune Checkpoint Blockade Combined With Lenvatinib

The combination of immune-checkpoint blockade (ICB) and lenvatinib has demonstrated robust clinical effects that are superior to those of monotherapies, but the synergistic anti-tumor mechanisms remain unclear. Exploring the synergistic molecular mechanisms and early identifying potential applicatio...

Full description

Bibliographic Details
Main Authors: Yuting Lu, Jiangtao Jin, Qi Du, Min Hu, Yuhan Wei, Miao Wang, Hongzhong Li, Qin Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
immune-checkpoint blockade
lenvatinib
synergistic mechanism
multi-omics analysis
malignancy
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.730240/full

Internet

https://www.frontiersin.org/articles/10.3389/fcell.2021.730240/full

Similar Items